Literature DB >> 20465721

Contrast-induced nephropathy in patients undergoing elective and urgent procedures.

Alessandro Mautone1, Jeremiah R Brown.   

Abstract

Contrast-induced nephropathy (CIN) is an acute and severe complication after contrast media administration. The most important step in preventing CIN is identifying high-risk patients. In this review, we evaluate and summarize the evidence regarding the CIN prophylaxis, including the withdrawal of the potentially nephrotoxic drugs, hydration by isotonic solution or NaHCO(3), pharmaceutical treatment with N-acetylcysteine (N-AC), adenosine antagonists, ascorbic acid, renal procedures including hemofiltration or dialysis, and to the optimal use of the contrast. We suggest it is possible to reduce the burden of CIN by carefully incorporating these recommendations. After review of published literature in this field, we conclude that the cornerstone of the CIN prevention should be combination of hydration (normal saline or NaHCO(3)) and the use of N-AC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20465721     DOI: 10.1111/j.1540-8183.2009.00523.x

Source DB:  PubMed          Journal:  J Interv Cardiol        ISSN: 0896-4327            Impact factor:   2.279


  7 in total

Review 1.  Comparative efficacy of pharmacological interventions for contrast-induced nephropathy prevention after coronary angiography: a network meta-analysis from randomized trials.

Authors:  Wen-Qi Ma; Yu Zhao; Ying Wang; Xi-Qiong Han; Yi Zhu; Nai-Feng Liu
Journal:  Int Urol Nephrol       Date:  2018-02-05       Impact factor: 2.370

2.  Astaxanthin attenuates contrast agent-induced acute kidney injury in vitro and in vivo via the regulation of SIRT1/FOXO3a expression.

Authors:  Nana Liu; Jing Chen; Dongmei Gao; Wenhua Li; Di Zheng
Journal:  Int Urol Nephrol       Date:  2018-01-24       Impact factor: 2.370

3.  Breviscapine attenuatted contrast medium-induced nephropathy via PKC/Akt/MAPK signalling in diabetic mice.

Authors:  Wenbin Jiang; Zhengwei Li; Wei Zhao; Hao Chen; Youyang Wu; Yi Wang; Zhida Shen; Jialin He; Shengyu Chen; Jiefang Zhang; Guosheng Fu
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

4.  Ascorbic acid effect on CIN incidence in diabetic patient after coronary angiography.

Authors:  Hossein Nough; Roya Daryachahei; Leila Hadiani; Mohammad Reza Najarzadegan; Masoud Mirzaee; Roya Hemayati; Mahdy Meidani; Roya Mousazadeh; Seyedhmahdyeh Namayandeh
Journal:  Adv Biomed Res       Date:  2016-04-19

5.  Contrast-induced nephropathy and allergic reaction in patients who were given intravenous contrast material in emergency department.

Authors:  İbrahim Caltekin; Pıxnar Yeşim Akyol; Fatih Esad Topal; Arif Karagöz; Erden Erol Ünlüer
Journal:  J Emerg Trauma Shock       Date:  2017 Jan-Mar

6.  Effect of Calcium Dobesilate in Preventing Contrast-Induced Nephropathy in Patients with Diabetes and Chronic Kidney Disease.

Authors:  Hao Zhang; Shao-Hua Guo; Zheng-Kai Xue; Ya-Ru Zhang; Jia-Rui Wang; Jing-Jin Che; Tong Liu; Hua-Yue Tao; Guang-Ping Li; Seung-Woon Rha; Swapnil-Zaman Ashraful-Haque; Kang-Yin Chen
Journal:  Clinics (Sao Paulo)       Date:  2021-10-18       Impact factor: 2.365

7.  Efficacy and Safety of Nicorandil in Preventing Contrast-Induced Nephropathy after Elective Percutaneous Coronary Intervention: A Pooled Analysis of 1229 Patients.

Authors:  Bin Yi; Shaoyan Mo; Yumei Jiang; Dingwu Yi; Jinwen Luo; Xiang Chen; Jian Rong
Journal:  J Interv Cardiol       Date:  2020-09-04       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.